Fibrosis, Liver Clinical Trials

10 recruiting

Fibrosis, Liver Trials at a Glance

10 actively recruiting trials for fibrosis, liver are listed on ClinicalTrialsFinder across 6 cities in 18 countries. The largest study group is Not Applicable with 4 trials, with the heaviest enrollment activity in Lisbon, Seville, and Antwerp. Lead sponsors running fibrosis, liver studies include Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Julius Clinical, and Centre Hospitalier Universitaire Saint Pierre.

Browse fibrosis, liver trials by phase

Treatments under study

About Fibrosis, Liver Clinical Trials

Looking for clinical trials for Fibrosis, Liver? There are currently 10 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Fibrosis, Liver trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Fibrosis, Liver clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 110 of 10 trials

Recruiting

Changes in Bile Acids and Microbiota in Patients With Hepatitis D Treated With Bulvertide

Hepatocellular CarcinomaHIV InfectionsCirrhosis, Liver+6 more
Fondazione Policlinico Universitario Agostino Gemelli IRCCS20 enrolled1 locationNCT07429864
Recruiting

Endoscopic Ultrasound Shear Wave Elastography Study

MASLDFibrosis, LiverChronic Liver Disease+1 more
Olympus Corporation of the Americas300 enrolled2 locationsNCT06592820
Recruiting
Not Applicable

Screening for Chronic Liver Diseases in General Population

Fibrosis, Liver
University Hospital, Montpellier260 enrolled1 locationNCT06366425
Recruiting
Not Applicable

Safety and Effectiveness of Sulfasalazine in the Treatment of Liver Fibrosis/Cirrhosis.

Cirrhosis, LiverFibrosis, Liver
The Second Affiliated Hospital of Chongqing Medical University330 enrolled2 locationsNCT06293378
Recruiting

Prevalence of Non-Alcoholic Fatty Liver Disease in Inflammatory Bowel Disease Patients

Inflammatory Bowel DiseasesFibrosis, LiverNAFLD+1 more
Centre Hospitalier Universitaire Saint Pierre150 enrolled1 locationNCT06814600
Recruiting
Not Applicable

Stem Cell Applications in Biliary Atresia Patients

Fibrosis, LiverBiliary AtresiaStem Cell
Necmi Kadıoğlu Hospital64 enrolled1 locationNCT06564740
Recruiting

Find HDV and Determine Its Status in Turkey

Hepatocellular CarcinomaCirrhosis, LiverFibrosis, Liver+2 more
Yaşar Bayındır, MD20,000 enrolled2 locationsNCT06248580
Recruiting

Global Research Initiative for Patients Screening on MASH

ObesityMetabolic SyndromeMASLD+6 more
Julius Clinical10,000 enrolled13 locationsNCT05651724
Recruiting
Not Applicable

The Liver Care Trial

AlcoholismAlcohol Use DisorderFibrosis, Liver+3 more
Zealand University Hospital408 enrolled2 locationsNCT05855031
Recruiting

The European NAFLD Registry

Hepatocellular CarcinomaObesityCardiovascular Diseases+9 more
Newcastle University10,000 enrolled37 locationsNCT04442334